Business Description
Eikon Therapeutics Inc
NAICS : 541714
SIC : 2834
ISIN : US2825641036
Total Employee Number:
384Description
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.01 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.46 | |||||
Debt-to-EBITDA | -1.63 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 25.47 | |||||
9-Day RSI | 37.92 | |||||
14-Day RSI | 43.45 | |||||
3-1 Month Momentum % | -13.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 11.75 | |||||
Quick Ratio | 11.75 | |||||
Cash Ratio | 11.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -8.8 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -23.37 | |||||
ROIC % | -59.48 | |||||
ROC (Joel Greenblatt) % | -71.17 | |||||
ROCE % | -25.79 | |||||
Moat Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.97 | |||||
Price-to-Tangible-Book | 0.97 | |||||
EV-to-EBIT | -1.65 | |||||
EV-to-EBITDA | -1.76 | |||||
EV-to-FCF | -2.09 | |||||
| Price-to-Net-Current-Asset-Value | 2.32 | |||||
| Price-to-Net-Cash | 2.51 | |||||
Earnings Yield (Greenblatt) % | -60.61 | |||||
FCF Yield % | -24.75 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:EIKN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eikon Therapeutics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.936 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 43.45 | ||
| 14-Day ATR ($) | 0.98135 | ||
| 20-Day SMA ($) | 10.78325 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 7.9 - 17.4 | ||
| Shares Outstanding (Mil) | 54.14 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eikon Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eikon Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-30 | In 137 days | ||
| Second quarter earnings results for 2026 | 2026-08-31 | In 46 days | ||
| General meeting for 2026 | 2026-07-16 | 10.19 (-2.11%) | ||
| First quarter earnings results for 2026 | 2026-05-11 | 9.96 (+8.38%) | ||
| Annual report for 2026 | 2026-03-30 | 9.81 (-4.48%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-30 | 9.81 (-4.48%) |
Show
Entries
Eikon Therapeutics Inc Frequently Asked Questions
What is Eikon Therapeutics Inc(EIKN)'s stock price today?
The current price of EIKN is $9.84. The 52 week high of EIKN is $17.40 and 52 week low is $7.90.
When is next earnings date of Eikon Therapeutics Inc(EIKN)?
The next earnings date of Eikon Therapeutics Inc(EIKN) is 2026-08-31 Est..
Does Eikon Therapeutics Inc(EIKN) pay dividends? If so, how much?
Eikon Therapeutics Inc(EIKN) does not pay dividend.
Guru Commentaries on NAS:EIKN
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Eikon Therapeutics Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers